Nectar Lifesciences Ltd (NECLIFE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Nectar Lifesciences Ltd reported sales of ₹0 Cr, operating profit of ₹-27 Cr (OPM -6,198%) and net profit of ₹-15 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
NECLIFE quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 6 0 0 5 1 0 1 0 Expenses 6 0 0 6 0 2 59 28 Operating Profit -1 0 0 -1 1 -2 -57 -27 OPM -10% -500% -500% -16% 77% - -4,437% -6,198% Other Income 7 8 -130 -62 -176 35 -24 3 Interest 0 0 0 0 0 30 6 0 Depreciation 0 0 0 1 0 0 0 0 Profit before tax 5 8 -130 -64 -176 3 -88 -24 Tax -2% 2% 0% -1% 0% -339% -22% -37% Net Profit 6 8 -130 -63 -176 14 -68 -15 EPS in Rs 0.25 0.35 -5.8 -2.82 -7.85 0.64 -3.5 -0.79
NECLIFE profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 1,665 1,520 1,682 1,664 2 2 Expenses 1,507 1,467 1,530 1,694 61 88 Operating Profit 159 53 152 -30 -59 -86 OPM 10% 3.5% 9% -1.8% -2,920% -3,520% Other Income 11 43 15 5 -228 -162 Interest 79 79 87 75 36 36 Depreciation 57 59 61 62 0 0 Profit before tax 34 -42 18 -162 -323 -285 Tax 26% -43% 73% -30% -9% - Net Profit 25 -24 5 -114 -293 -245 EPS in Rs 1.12 -1.08 0.22 -5.07 -15.08 -11.5 Dividend Payout 0% 0% 0% 0% 0% -
NECLIFE balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 22 22 22 22 19 Reserves 1,042 1,047 934 694 563 Borrowings 754 636 582 459 0 Other Liabilities 371 486 509 639 39 Total Liabilities 2,189 2,191 2,047 1,815 622 Fixed Assets 662 643 633 28 105 CWIP 78 66 57 0 0 Investments 1 1 1 1 13 Other Assets 1,449 1,482 1,357 1,786 504 Total Assets 2,189 2,191 2,047 1,815 622
NECLIFE cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 95 134 225 169 -349 Cash from Investing Activity 17 52 -17 -42 1,208 Cash from Financing Activity -119 -186 -205 -128 -767 Net Cash Flow -8 0 2 -1 93 Free Cash Flow 110 183 195 126 -341 CFO/OP 60% 252% 148% -574% 594%
NECLIFE ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 98 67 82 76 0 Inventory Days 197 212 215 184 - Days Payable 112 100 127 117 - Cash Conversion Cycle 182 179 170 143 0 Working Capital Days 73 77 63 43 26,618 ROCE 5% 0% 6% -5% -5%